Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4332166 | 4122504 | I | 4332166-6 | 20030530 | 20040311 | 20040331 | EXP | EWC040338419 | ELI LILLY AND COMPANY | 90 | YR | F | N | 89 | KG | 20040324 | MD |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4332166 | 1004762059 | PS | ZYPREXA | 1 | ORAL | 10 MG/1 DAY | D | 20592 | |||
| 4332166 | 1004773700 | C | LORAZEPAM | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4332166 | 1004762059 | DISORIENTATION |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4332166 | DE |
Reactions reported
| Event ID | PT |
|---|---|
| 4332166 | AGRANULOCYTOSIS |
| 4332166 | CARDIOMYOPATHY |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4332166 | FGN |
| 4332166 | HP |
| 4332166 | OTH |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 4332166 | 1004762059 | 20030520 |